OPK OPKO HEALTH
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about OPKO HEALTH: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 7 reports on OPK from 6 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barrington Research raised its target from $1.50 (set 2 Mar 2026) to $2.25 on 16 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barrington Research | Michael Petusky | Buy | 16 Oct 2026 | 2.25 USD |
| H.C. Wainwright | Yi Chen | Buy | 16 Oct 2026 | 3.00 USD |
| JPMorgan | Brian Cheng | Hold | 20 Nov 2025 | — |
| Ladenburg Thalmann | Kevin M Degeeter | Buy | 27 Feb 2026 | 3.00 USD |
| Piper Sandler | Edward Tenthoff | Buy | 16 Oct 2026 | 4.00 USD |
| UBS | Unnamed analyst | — | 16 Oct 2026 | 4.00 USD |
| Weiss Ratings | Unnamed analyst | — | 13 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 28 Sep 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:15 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.